Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in Korea

Study Identifier
191622-139
CT.gov Identifier
NCT01976611
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Migraine - General
  • Neuroscience - Other
    • Study Drug
  • botulinum toxin Type A
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Patients treated with botulinum toxin Type A for chronic migraine in clinical practice.
    Exclusion Criteria:
    * None.

    Protocol Summary

    This study is a Post-Marketing Surveillance study in Korea to evaluate the safety and efficacy of botulinum toxin Type A to treat Chronic Migraine in clinical practice.

    Study Locations

    Location
    Status
    Location
    Seoul, Republic of Korea
    Status
    Not applicable